Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 24, 2024. The transactions were executed in the open market with prices ranging from $107.16 to $109.91 per share, resulting in a total market value of $1,624,835.94. Following the sale, Afeyan directly holds 2,041,931 shares. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. amount to 9,666,038 shares of Moderna's common stock.